news
Four UK CROs announce collaboration to work on potential COVID-19 therapeutics
A group of four CROs at BioCity Nottingham have joined forces to collectively work on the research of COVID-19 therapies.
List view / Grid view
Contract Research Organisations (CROs)
article
The opportunities for CDMOs in the pharmaceutical industry
A PricewaterhouseCoopers report has highlighted the directions that the growth of the contract development and manufacturing organisation (CDMO) outsourcing market will take in the near future.
news
UK vaccine clinical trial outsourcing expansion continues
An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
news
Global CRO market to reach $71.7 billion by 2024, says research
A report suggests the need for novel therapies and cost-effective R&D will drive growth for contract research organisations, especially in Asia-Pacific.
whitepaper
Whitepaper: Analytical criteria in bacterial endotoxin testing using LAL and rFC
This article covers the analytical criteria that apply to Bacterial Endotoxin Testing (BET) using Limulus Amebocyte Lysate (LAL) or recombinant Horseshoe crab Factor C (rFC) for the bioactivity determination of endotoxin in aqueous solutions, such as pharmaceuticals and medical device extracts. It explains the importance of these criteria for accurate…
article
The data challenges of research & development and collaboration
In the biopharmaceuticals industry today, only 13 percent of therapeutics that enter Phase 1 of clinical trials go on to launch1 – and the total journey from R&D to market can be anywhere between eight and 12 years.2
whitepaper
Whitepaper: Ten things you should know before contracting a custom synthesis project
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
whitepaper
Whitepaper: Meeting modern data integrity and compliance requirements
FDA was perhaps understating a point when it said in its April 2016 Draft Guidance: Data Integrity and Compliance with cGMP that the increasing number of data integrity-related cGMP violations identified during its inspections was ‘troubling’...
article
Outsourcing: Current trends in the CDMO sector
Patheon’s Joe Principe examines current trends in outsourcing, highlighting the importance of investment in CDMO partnerships...
article
Alliance management organisational development: A Bayer perspective
4 April 2017 | By Christoph Huwe, Strategic Alliance Manager Therapeutics at Bayer Pharmaceuticals, Global External Innovation & Alliances
Ahead of the 7th Annual Strategic Alliance Management for Pharma conference, we spoke with Bayer's Christoph Huwe about the organisational development of alliance management...
news
Rainin TerraRacks enhance process security for CROs
3 November 2016 | By METTLER TOLEDO AG
Pelago Bioscience in Solna, Sweden, is taking advantage of the enhanced process security and convenience offered by METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks...
article
The evolution of the Contract Research Organisation and the future of the pharmaceutical industry
This article discusses how the pharmaceutical industry can leverage its competencies in outsourcing to accelerate time to market, improve quality and increase innovation at all stages of the drug discovery and development process. The pharmaceutical industry is being battered by a perfect storm of not just one but three major…
article
Under the microscope with Gareth Jenkins from AMRI
Founded in 1991, AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organisation, with locations in the US, Europe and Asia. The company provides fully integrated drug discovery, development and manufacturing services to the pharmaceutical and biotechnology industries.
article
Outsourcing in early drug discovery: Evolution and opportunities
26 April 2012 | By Jayshree Mistry, Paul Lloyd, Kevin Oliver and Peter North, GlaxoSmithKline R&D and Duncan Judd, Awridian
This article describes the evolution of outsourcing within early drug discovery at GlaxoSmithKline (GSK), specifically for chemistry services applied to developing a compound from the screening hit through lead optimisation. It will touch on different business models, factors to consider when selecting potential CROs, the benefits of outsourcing and CRO…
product
HEOS® by SCYNEXIS
9 March 2012 | By Accelrys
Learn more about HEOS® by SCYNEXIS - a SaaS workspace in which multiple, disparate companies, academic collaborators or CROs can exchange scientific data securely and in real-time.
